Clindamycin
Clindamycin is a semisynthetic, broad-spectrum antibiotic derived from lincomycin. It inhibits bacterial protein synthesis by causing premature dissociation of peptidyl-tRNA from the ribosome. This mechanism is utilized in research applications for studying bacterial pathogenesis and antibiotic action in both in vitro and in vivo models.
Product Specifications
CAS Number
18323-44-9
Product Name Alternative
Clinimycin, Clindamycin, Chlolincocin, Bacterial, Antibiotic, broad-spectrum, bacteriostatic, Parasite, inhibit, lincosamide, malaria, Inhibitor, Sobelin
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery
Purity
98.04% (May vary between batches)
Solubility
DMSO:45 mg/mL (105.89 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; Ethanol:79 mg/mL (185.89 mM)
Smiles
[C@@H] (NC (=O) [C@@H]1C[C@@H] (CCC) CN1C) ([C@H] (C) Cl) [C@]2 (O[C@H] (SC) [C@H] (O) [C@@H] (O) [C@H]2O) [H]
Molecular Formula
C18H33ClN2O5S
Molecular Weight
424.98
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
